Anticoronavirus and Immunomodulatory Phenolic Compounds: Opportunities and Pharmacotherapeutic Perspectives.
Biomolecules
; 11(8)2021 08 23.
Статья
в английский
| MEDLINE | ID: covidwho-1367768
ABSTRACT
In 2019, COVID-19 emerged as a severe respiratory disease that is caused by the novel coronavirus, Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2). The disease has been associated with high mortality rate, especially in patients with comorbidities such as diabetes, cardiovascular and kidney diseases. This could be attributed to dysregulated immune responses and severe systemic inflammation in COVID-19 patients. The use of effective antiviral drugs against SARS-CoV-2 and modulation of the immune responses could be a potential therapeutic strategy for COVID-19. Studies have shown that natural phenolic compounds have several pharmacological properties, including anticoronavirus and immunomodulatory activities. Therefore, this review discusses the dual action of these natural products from the perspective of applicability at COVID-19.
ключевые слова
Полный текст:
Имеется в наличии
Коллекция:
Международные базы данных
база данных:
MEDLINE
Основная тема:
Antiviral Agents
/
Protease Inhibitors
/
Flavonoids
/
Phytochemicals
/
COVID-19 Drug Treatment
/
Immunologic Factors
Пределы темы:
Животные
/
Люди
Язык:
английский
Год:
2021
Тип:
Статья
Аффилированная страна:
Biom11081254
Документы, близкие по теме
MEDLINE
...
LILACS
LIS